These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 820188)

  • 1. Proceedings: Cost savings/benefit analysis of drug abuse treatment.
    Scanlon JC
    Am J Drug Alcohol Abuse; 1976; 3(1):95-101. PubMed ID: 820188
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: How can we compare the effectiveness of different programs and modalities?
    Barr HL
    Am J Drug Alcohol Abuse; 1976; 3(1):103-14. PubMed ID: 59543
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatment programs in Pennsylvania. A statewide evaluation.
    Ball JC; Graff H
    Am J Public Health; 1975 Jun; 65(6):592-8. PubMed ID: 1093419
    [No Abstract]   [Full Text] [Related]  

  • 4. A revised treatment typology based on the DARP.
    Cole SG; James LR
    Am J Drug Alcohol Abuse; 1975; 2(1):37-49. PubMed ID: 1190193
    [No Abstract]   [Full Text] [Related]  

  • 5. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract]   [Full Text] [Related]  

  • 6. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
    Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
    NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug abuse treatment process: a review of the literature.
    Allison M; Hubbard RL
    Int J Addict; 1985 Sep; 20(9):1321-45. PubMed ID: 3000959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating outcome criteria used in methadone maintenance programs.
    Cohen M; Howard A; Klein DF; Newfield K
    Int J Addict; 1976; 11(2):283-94. PubMed ID: 1262095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up evaluation of treatment of drug abuse during 1969 to 1972.
    Simpson DD; Savage LJ; Lloyd MR
    Arch Gen Psychiatry; 1979 Jul; 36(7):772-80. PubMed ID: 454093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical connection: drugs and crime.
    Leukefeld CG
    Int J Addict; 1985; 20(6-7):1049-64. PubMed ID: 3908335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of present treatment modalities: research with DARP admissions, 1969-1973.
    Sells SB; Demaree RG; Simpson DD; Joe GW
    Ann N Y Acad Sci; 1978; 311():270-81. PubMed ID: 217292
    [No Abstract]   [Full Text] [Related]  

  • 13. IDAP--five-year results.
    Senay EC; Jaffe JH; Chappel JN; Renault P; Wright M; Lawson C; Charnett C; diMenza S
    Proc Natl Conf Methadone Treat; 1973; 2():1437-64. PubMed ID: 4808299
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of drug abuse rehabilitation efforts: a review.
    Quinones MA; Doyle KM; Sheffet A; Louria DB
    Am J Public Health; 1979 Nov; 69(11):1164-9. PubMed ID: 507249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral health issue brief: drug courts: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-9. PubMed ID: 12875266
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of employment criteria for measuring the effectiveness of methadone maintenance programs.
    Bloch HI; Ellis RD; Spielman CR
    Int J Addict; 1977 Feb; 12(1):161-72. PubMed ID: 863559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating the drug abuser.
    Doyle KM; Quinones MA; Louria DB
    Public Health Rev; 1982; 10(1):77-98. PubMed ID: 6813913
    [No Abstract]   [Full Text] [Related]  

  • 18. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB; Simpson DD
    Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
    [No Abstract]   [Full Text] [Related]  

  • 19. A follow-up study of former residents of a therapeutic community.
    Collier WV; Hijazi YA
    Int J Addict; 1974; 9(6):805-26. PubMed ID: 4448560
    [No Abstract]   [Full Text] [Related]  

  • 20. The phenomenon of self-perpetuation in Synanon-type drug treatment programs.
    Scott D; Goldberg HL
    Hosp Community Psychiatry; 1973 Apr; 24(4):231-3. PubMed ID: 4693122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.